TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
about
Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.
P2860
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
TFEB-VEGFA (6p21.1) co-amplifi ...... tions for clinical management.
@en
TFEB-VEGFA
@nl
type
label
TFEB-VEGFA (6p21.1) co-amplifi ...... tions for clinical management.
@en
TFEB-VEGFA
@nl
prefLabel
TFEB-VEGFA (6p21.1) co-amplifi ...... tions for clinical management.
@en
TFEB-VEGFA
@nl
P2093
P2860
P1433
P1476
TFEB-VEGFA (6p21.1) co-amplifi ...... tions for clinical management.
@en
P2093
Binu Porath
Bradley C Leibovich
Brian A Costello
George Vasmatzis
Jeannette G Rustin
John C Cheville
R Houston Thompson
Sarah H Johnson
Sounak Gupta
P2860
P2888
P304
P356
10.1038/MODPATHOL.2017.24
P577
2017-03-24T00:00:00Z